Table of Contents Author Guidelines Submit a Manuscript
Anemia
Volume 2013, Article ID 169107, 10 pages
http://dx.doi.org/10.1155/2013/169107
Clinical Study

Direct Comparison of the Safety and Efficacy of Ferric Carboxymaltose versus Iron Dextran in Patients with Iron Deficiency Anemia

1Vital Prospects Clinical Research Institute, PC, Tulsa, OK 74136, USA
2Luitpold Pharmaceuticals, Inc., Norristown, PA 19403, USA
3Department of Pathology, Albert Einstein College of Medicine, Bronx, NY 10461, USA

Received 29 May 2013; Revised 25 July 2013; Accepted 26 July 2013

Academic Editor: Aurelio Maggio

Copyright © 2013 Iftikhar Hussain et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [36 citations]

The following is the list of published articles that have cited the current article.

  • Michael Auerbach, and Iain C. Macdougall, “Safety of intravenous iron formulations: facts and folklore,” Blood Transfusion, vol. 12, no. 3, pp. 296–300, 2014. View at Publisher · View at Google Scholar
  • Ambroise Wonkam, Maryam Bibi Rumaney, Valentina Josiane Ngo Bitoungui, Anna Alvera Vorster, Raj Ramesar, and Jeanne Ngogang, “Coinheritance of sickle cell anemia and alpha-thalassemia delays disease onset and could improve survival in Cameroonian's patients (Sub-Saharan Africa),” American Journal of Hematology, vol. 89, no. 6, pp. 664–665, 2014. View at Publisher · View at Google Scholar
  • Weiwei Gan, Hongbin Zhang, Yuqi Zhang, and XueQin Hu, “Biosynthesis of oligodextrans with different Mw by synergistic catalysis of dextransucrase and dextranase,” Carbohydrate Polymers, 2014. View at Publisher · View at Google Scholar
  • Y C Fierz, R Kenmeni, A Gonthier, F Lier, F Pralong, and P Coti Bertrand, “Severe and prolonged hypophosphatemia after intravenous iron administration in a malnourished patient,” European Journal of Clinical Nutrition, 2014. View at Publisher · View at Google Scholar
  • Jorge Eduardo Toblli, and Margarita Angerosa, “Optimizing iron delivery in the management of anemia: patient considerations and the role of ferric carboxymaltose,” Drug Design Development And Therapy, vol. 8, pp. 2475–2491, 2014. View at Publisher · View at Google Scholar
  • Kurinchi Selvan Gurusamy, Myura Nagendran, Jack F Broadhurst, Stefan D Anker, and Toby RichardsCochrane Database of Systematic Reviews, 2014. View at Publisher · View at Google Scholar
  • Lawrence T. Goodnough, and David B. Bregman, “Experience with intravenous ferric carboxymaltose in patients with iron deficiency anemia,” Therapeutic Advances in Hematology, vol. 5, no. 2, pp. 48–60, 2014. View at Publisher · View at Google Scholar
  • O. Díaz-Cambronero, S. Matoses-Jaén, N. García-Claudio, N. García-Gregorio, and J. Molins-Espinosa, “Manejo preoperatorio de la anemia en cirugía oncológica,” Revista Española de Anestesiología y Reanimación, vol. 62, pp. 45–51, 2015. View at Publisher · View at Google Scholar
  • Georgia Kaiafa, Ilias Kanellos, Christos Savopoulos, Nikolaos Kakaletsis, George Giannakoulas, and Apostolos I. Hatzitolios, “Is anemia a new cardiovascular risk factor?,” International Journal of Cardiology, vol. 186, pp. 117–124, 2015. View at Publisher · View at Google Scholar
  • U. Schatz, B.M.W. Illigens, T. Siepmann, B. Arneth, G. Siegert, D. Siegels, F. Heigl, R. Hettich, W. Ramlow, H. Prophet, S.R. Bornstein, and U. Julius, “TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients – A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltose,” Atherosclerosis Supplements, vol. 18, pp. 199–208, 2015. View at Publisher · View at Google Scholar
  • Gillian M. Keating, “Ferric carboxymaltose: a guide to its use in iron deficiency,” Drugs & Therapy Perspectives, 2015. View at Publisher · View at Google Scholar
  • Gillian M. Keating, “Ferric Carboxymaltose: A Review of Its Use in Iron Deficiency,” Drugs, vol. 75, no. 1, pp. 101–127, 2015. View at Publisher · View at Google Scholar
  • Rebeca Sánchez González, Hugo Guillermo Ternavasio-de la Vega, Leticia Moralejo Alonso, Sandra Inés Revuelta, and Aurelio Fuertes Martín, “Hipofosfatemia asociada a la administración intravenosa de hierro carboximaltosa en pacientes con anemia ferropénica. Un efecto secundario frecuente,” Medicina Clínica, 2015. View at Publisher · View at Google Scholar
  • Todd A. Koch, Jennifer Myers, and Lawrence Tim Goodnough, “Intravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations,” Anemia, vol. 2015, pp. 1–10, 2015. View at Publisher · View at Google Scholar
  • Michael Auerbach, David Henry, Giancarlo Liumbruno, Francesco Locatelli, Iain Macdougall, Manuel Munoz, David Rampton, George Rodgers, Aryeh Shander, John Adamson, Andreas Bircher, Christian Breymann, Steven Fishbane, Anat Gafter-Gvili, Christoph Gasche, Jeffrey Gilreath, and Giuliano Grazzini, “On the safety of intravenous iron, evidence trumps conjecture,” Haematologica, vol. 100, no. 5, pp. E214–E215, 2015. View at Publisher · View at Google Scholar
  • Olus Api, Christian Breyman, Mustafa Çetiner, Cansun Demir, and Tevfik Ecder, “Diagnosis and treatment of iron deficiency anemia during pregnancy and the postpartum period: Iron deficiency anemia working group consensus report,” Turk Jinekoloji ve Obstetrik Dernegi Dergisi, vol. 12, no. 3, pp. 173–181, 2015. View at Publisher · View at Google Scholar
  • Ugo Salvadori, Marco Sandri, Cristina Melli, Francesca Polese, Maria Simeoni, Stefano Capelli, and Ahmad Al-Khaffaf, “Ferric carboxymaltose reduces the number of red blood cell units transfused and allows transfusion independence to be obtained in patients with iron deficiency anemia secondary to gastrointestinal chronic blood loss,” Transfusion, 2016. View at Publisher · View at Google Scholar
  • William E. Strauss, Naomi V. Dahl, Zhu Li, Gloria Lau, and Lee F. Allen, “Ferumoxytol versus iron sucrose treatment: a post-hoc analysis of randomized controlled trials in patients with varying renal function and iron deficiency anemia,” BMC Hematology, vol. 16, no. 1, 2016. View at Publisher · View at Google Scholar
  • Pascal Knüfermann, and Holger Haas, “Blutmanagement in der Orthopädie und Unfallchirurgie,” Patientenzentrierte Medizin in Orthopädie und Unfallchirurgie, pp. 157–172, 2016. View at Publisher · View at Google Scholar
  • Rebeca Sánchez González, Hugo Guillermo Ternavasio-de la Vega, Leticia Moralejo Alonso, Sandra Inés Revuelta, and Aurelio Fuertes Martín, “Intravenous ferric carboxymaltose-associated hypophosphatemia in patients with iron deficiency anemia. A common side effect,” Medicina Clínica (English Edition), 2016. View at Publisher · View at Google Scholar
  • Yu-Qi Zhang, Ruo-Han Li, Hong-Bin Zhang, Min Wu, and Xue-Qin Hu, “Purification, characterization, and application of a thermostable dextranase from Talaromyces pinophilus,” Journal of Industrial Microbiology & Biotechnology, 2016. View at Publisher · View at Google Scholar
  • Jennifer C. Cook, Richard H. Tran, J. Herbert Patterson, and Jo E. Rodgers, “Evolving therapies for the management of chronic and acute decompensated heart failure,” American Journal of Health-System Pharmacy, vol. 73, no. 21, pp. 1745–1754, 2016. View at Publisher · View at Google Scholar
  • Pramoda Koduru, and Bincy P. Abraham, “The role of ferric carboxymaltose in the treatment of iron deficiency anemia in patients with gastrointestinal disease,” Therapeutic Advances In Gastroenterology, vol. 9, no. 1, pp. 76–85, 2016. View at Publisher · View at Google Scholar
  • Muzaffer Keklik, Uğur Kalan, Serdal Korkmaz, Gülşah Akyol, Bilal Aygün, and Ertuğrul Keklik, “Evaluation of iron sucrose and ferric carboxymaltose therapies in patients with iron deficiency anemia,” Erciyes Tip Dergisi, vol. 39, no. 2, pp. 59–62, 2017. View at Publisher · View at Google Scholar
  • Nalini Sharma, J. Lalnunnem Thiek, Tanie Natung, and Santa Singh Ahanthem, “Comparative Study of Efficacy and Safety of Ferric Carboxymaltose Versus Iron Sucrose in Post-partum Anaemia,” The Journal of Obstetrics and Gynecology of India, 2017. View at Publisher · View at Google Scholar
  • Jürgen Stein, Ayşegül Aksan, Karima Farrag, Axel Dignass, and Heinfried H Radeke, “Management of inflammatory bowel disease-related anemia and iron deficiency with specific reference to the role of intravenous iron in current practice,” Expert Opinion on Pharmacotherapy, pp. 1–17, 2017. View at Publisher · View at Google Scholar
  • Palle Bager, Christian L. Hvas, and Jens F. Dahlerup, “Drug-specific hypophosphatemia and hypersensitivity reactions following different intravenous iron infusions,” British Journal of Clinical Pharmacology, 2017. View at Publisher · View at Google Scholar
  • Ramy H. Bishay, Kirtan Ganda, and Markus J. Seibel, “Long-term iron polymaltose infusions associated with hypophosphataemic osteomalacia: a report of two cases and review of the literature,” Therapeutic Advances in Endocrinology and Metabolism, vol. 8, no. 1-2, pp. 14–19, 2017. View at Publisher · View at Google Scholar
  • Gary R. Lichtenstein, and Jane E. Onken, “Improved Hemoglobin Response with Ferric Carboxymaltose in Patients with Gastrointestinal-Related Iron-Deficiency Anemia Versus Oral Iron,” Digestive Diseases and Sciences, 2018. View at Publisher · View at Google Scholar
  • Lesley J. Scott, “Ferric Carboxymaltose: A Review in Iron Deficiency,” Drugs, 2018. View at Publisher · View at Google Scholar
  • Birgit Ehlken, Lennart Nathell, Annegret Gohlke, Derya Bocuk, Massoud Toussi, and Stefan Wohlfeil, “Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ between 2014 and 2017,” Drug Safety, 2018. View at Publisher · View at Google Scholar
  • Carla Gargallo-Puyuelo, Erika Alfambra, Jose García-Erce, and Fernando Gomollon, “Iron Treatment May Be Difficult in Inflammatory Diseases: Inflammatory Bowel Disease as a Paradigm,” Nutrients, vol. 10, no. 12, pp. 1959, 2018. View at Publisher · View at Google Scholar
  • Liu Yang, Nandi Zhou, and Yaping Tian, “Purification, characterization, and biocatalytic potential of a novel dextranase from Chaetomium globosum,” Biotechnology Letters, vol. 40, no. 9-10, pp. 1407–1418, 2018. View at Publisher · View at Google Scholar
  • Burckhardt, “Disabling osteomalacia,” Osteologie, vol. 27, no. 1, pp. 20–23, 2018. View at Publisher · View at Google Scholar
  • Constantinos Bakogiannis, Alexandros Briasoulis, Dimitrios Mouselimis, Anastasios Tsarouchas, Nikolaos Papageorgiou, Christodoulos Papadopoulos, Nikolaos Fragakis, and Vassilios Vassilikos, “Iron deficiency as therapeutic target in heart failure: a translational approach,” Heart Failure Reviews, 2019. View at Publisher · View at Google Scholar
  • Hye Kyoung Sung, Erfei Song, James Won Suk Jahng, Kostas Pantopoulos, and Gary Sweeney, “Iron induces insulin resistance in cardiomyocytes via regulation of oxidative stress,” Scientific Reports, vol. 9, no. 1, 2019. View at Publisher · View at Google Scholar